CHIRON BIOTECH
Innovative products and solutions for the biomedical industry, regenerative medicine and drug delivery.
CHIRON BIOTECH
Social Links:
Industry:
3D Printing 3D Technology Biotechnology
Founded:
2021-01-01
Website Url:
http://www.chiron-biotech.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Person Schema Gravatar Profiles
Founder
Official Site Inspections
http://www.chiron-biotech.com
- Host name: 179.36.149.34.bc.googleusercontent.com
- IP address: 34.149.36.179
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "CHIRON Biotech"
About us โ Chiron Biotech
The project Chiron is funded by ... Contacts: [email protected]. Role in the project: Project Coordinator and Principal investigator. Ion Martinez de Apellaniz. Biomechanical engineer, โฆSee details»
Chiron Corporation - Wikipedia
Chiron Corporation was an American multinational biotechnology firm founded in 1981, based in Emeryville, California, that was acquired by Novartis on April 20, 2006. It had offices and facilities in eighteen countries on five continents. Chiron's business and research was in three main areas: biopharmaceuticals, vaccines, and blood testing. Chiron's vaccines and blood testing units were combined to form Novartis Vaccines and Diagnostics, while Chiron BioPharmaceuticals was intโฆSee details»
CHIRON Biotech - Crunchbase Company Profile & Funding
Organization. CHIRON Biotech . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... Alternatives and possible competitors to CHIRON โฆSee details»
Chiron Corporation - Crunchbase Company Profile
Chiron Corporation was an American biotechnology company engaged in biopharmaceuticals, vaccines and blood testing. The company was founded in 1981 by William Rutter. Chiron initially concentrated in the field of โฆSee details»
CHIRON Recombinant Proteins - BIO International Convention | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... CHIRON, today as a division โฆSee details»
Chiron begins โ Chiron Biotech
Chiron begins Chiron project officially started with the consortium team working on developing the bioprinter. Key milestone is the delivery of the full bioprinting platform to the University of โฆSee details»
Chiron Corporation - WikiMili, The Best Wikipedia Reader
Apr 16, 2024 Chiron Corporation (/ ห k aษช r ษ n / KY-ron) [1] was an American multinational biotechnology firm founded in 1981, based in Emeryville, California, that was acquired by Novartis on April 20, 2006. It had offices and facilities in eighteen countries on five continents. Chiron's business and research was in three main areas: biopharmaceuticals, vaccines, and blood testing.See details»
Chiron Corporation - PHARMACEUTICAL ONLINE
Oct 2, 2000 Chiron Corporation is a leading biotechnology company that participates in three global healthcare markets: biopharmaceuticals, blood testing, and vaccines. The company is โฆSee details»
Chiron Biotech โ VoxelMatters - The largest database of additive ...
Smart bioprinting platform for biomedical research Bioprinting products and solutions for the biomedical industry, regenerative medicine and drug delivery. First 3D bio-inkjet multimaterial โฆSee details»
Chiron Corp | Encyclopedia.com
Jun 11, 2018 Chiron Corporation. 4560 Morton Street Emeryville, California 94608-2916 U.S.A. (510) 655-8730 Fax: (510) 655-9910. Public Company Incorporated: 1981 Employees: 2,164 โฆSee details»
Chiron -- From startup to global biotech giant - SFGATE
May 28, 2001 In 1991, Chiron absorbed parts of Cetus Corp., the East Bay biotech firm started in 1971 by molecular biologist Ronald Cape. In 1995, Chiron sold half of itself to the Swiss โฆSee details»
Chiron Corporation -- Company History
Chiron licensed this new vaccine, created for the prevention of hepatitis B, to the pharmaceutical giant Merck & Co., Inc. Pending Food and Drug Administration (FDA) approval, Merck would market the vaccine and pay royalties to Chiron. Unlike many start-up biotech firms at that time, Chiron did not intend to become a fully integrated ...See details»
Chiron Licenses Compound to TB Drug Development Group
Jan 31, 2002 Emeryville, California, Feb. 1 (Bloomberg) -- Chiron Corp. agreed to license rights for an experimental compound to a non-profit group dedicated to developing new tuberculosis โฆSee details»
Collaboration between medac and start-up chiron to develop โฆ
Nov 12, 2024 Find articles on 57,945 keywords in life science, biotech, pharma, biology and related science disciplines in the encyclopedia.. ... In this context the pharmaceutical company โฆSee details»
Chips Off The Old Block / Alums of Genentech, Chiron, Cetus ... - SFGATE
Apr 2, 2001 Chips Off The Old Block / Alums of Genentech, Chiron, Cetus make Bay Area the capital of biotech industry By Tom Abate April 2, 2001 Second of a two-part series on the biotechnology industry.See details»
Chiron Corp. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Chiron Corp. with its drug pipeline, therapeutic area, technology platform, 28 clinical trials, 89 news, and 2 literature, Disease Domain:Infectious Diseases, Immune System Diseases, โฆSee details»
Novartis bids $4.5B for remaining shares of Chiron - Fierce Biotech
Aug 31, 2005 Novartis has offered $4.5 billion to acquire all the remaining shares of Chiron it doesn't already own. To be successful, about half of the outstanding shareholders in Chiron โฆSee details»
Chiron | Lifesciences @ Work
Chiron is an organ-on-chip (OoC) company possessing patent-protected technology for mechanically stimulating human cells, which was leveraged to develop an in-vitro joint model โฆSee details»
Applications โ Chiron Biotech
Chiron team will investigate is the possibility to jet cells through the bioprinting platform at an unprecedented speed and resolution. The possibility to 3dprint cells and combine the cells with โฆSee details»
chiron | Our Science
Applying chironโs patented technology to the stimulation of tissue. To complement the Cartilage-on-Chip Platform, chiron created the Move It. Instead of stimulating single cartilage cells or โฆSee details»